This website uses cookies to enhance the user experience.
P

PHARMA HOLDINGS AS917 999 244

Research
Limited company
Killengreens gate 8 9008 TROMSØ, Norge

PHARMA HOLDINGS AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board
Years since formation
8 years
since Nov 4, 2016
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
1,011,744
1 share class
Total number of shareholders
289
152 companies, 137 persons

Financials

Total operating income 2023
1,740,889
NOK
Annual total result 2023
-15,173,542
NOK
Total equity 2023
16,353,280
NOK
Last update: Aug 29, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman
47.51 %
indirectly
Board Member-
Board Member-
Board Member-

Others

NameRoleShares
E
ERNST & YOUNG AS
Auditor-
B
BDO AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Chairman
47.51 %
indirectly
-
7.28 %
indirectly
-
4.07 %
indirectly
-
3.99 %
indirectly
-
2.61 %
directly < 0.01 %
indirectly 2.6 %
-
2.54 %
indirectly
-
1.41 %
indirectly
-
1.41 %
indirectly
-
1.35 %
indirectly
-
1.35 %
indirectly
Last update: Oct 26, 2024

Ownership

Company shareholders

NameShare classNumber of sharesShare
C
CARE HOLDING AS
NO0010797350
475,673
47.02 %
T
TAJ HOLDING AS
NO0010797350
128,422
12.69 %
B
NO0010797350
64,272
6.35 %
A
AGIR AS
NO0010797350
52,622
5.2 %
C
CONSEPT EIENDOM AS
NO0010797350
50,000
4.94 %
J
JAHATT AS
NO0010797350
41,137
4.07 %
O
ODD BERG AS
NO0010797350
13,131
1.3 %
H
HARILA EIENDOM AS
NO0010797350
13,000
1.28 %
W
WAATVIKA AS
NO0010797350
12,965
1.28 %
T
TUT AS
NO0010797350
12,500
1.24 %
NO0010797350
12,500
1.24 %
NO0010797350
12,159
1.2 %
S
STOKO AS
NO0010797350
10,015
0.99 %
H
HOPEN INVEST AS
NO0010797350
10,010
0.99 %
S
SEED CAPITAL AS
NO0010797350
10,000
0.99 %
T
TAVE INVEST AS
NO0010797350
9,107
0.9 %
L
LYSNES INVEST AS
NO0010797350
8,807
0.87 %
P
PICASSO AS
NO0010797350
7,861
0.78 %
P
PER STRAND EIENDOM AS
NO0010797350
6,992
0.69 %
N
NORINNOVA INVEST AS
NO0010797350
4,950
0.49 %
S
SEED CONSULTING AS
NO0010797350
3,000
0.3 %
NO0010797350
3,000
0.3 %
K
KAUPALOKI AS
NO0010797350
2,297
0.23 %
4
4 LB INVEST AS
NO0010797350
1,808
0.18 %
N
NORINNOVA AS
NO0010797350
1,760
0.17 %
NO0010797350
1,722
0.17 %
NO0010797350
1,715
0.17 %
NO0010797350
1,515
0.15 %
S
SÅKORNINVEST MIDT-NORGE AS
NO0010797350
1,511
0.15 %
H
HAUKELAND AS
NO0010797350
1,381
0.14 %
NO0010797350
1,340
0.13 %
K
KRÆMER AS
NO0010797350
1,220
0.12 %
J
JESEM AS
NO0010797350
1,143
0.11 %
T
TROMS KRAFT AS
NO0010797350
1,059
0.1 %
H
HARILA INVEST AS
NO0010797350
1,047
0.1 %
Ø
ØKSNES INVEST AS
NO0010797350
917
0.09 %
M
MYRBAKK EIENDOM AS
NO0010797350
767
0.08 %
K
KRANE AS
NO0010797350
767
0.08 %
L
LUKAS I AS
NO0010797350
641
0.06 %
J
JPB AS
NO0010797350
618
0.06 %
B
BODØ LEGETJENESTER AS
NO0010797350
617
0.06 %
S
SUCABE INVEST AS
NO0010797350
605
0.06 %
G
GADD HOLDING AS
NO0010797350
588
0.06 %
NO0010797350
553
0.05 %
H
HEYERN AS
NO0010797350
534
0.05 %
P
PONGO AS
NO0010797350
518
0.05 %
L
LÅS & BESLAG CONSULT AS
NO0010797350
503
0.05 %
H
HÅKON HANSEN AS
NO0010797350
490
0.05 %
NO0010797350
484
0.05 %
S
SIRIUS EIENDOM AS
NO0010797350
476
0.05 %
C
CAVA HOLDING AS
NO0010797350
416
0.04 %
NO0010797350
414
0.04 %
S
SPAR KAPITAL INVESTOR AS
NO0010797350
406
0.04 %
T
T BERSET HOLDING AS
NO0010797350
377
0.04 %
W
WEAB INVEST AS
NO0010797350
374
0.04 %
NO0010797350
361
0.04 %
N
NORGES RÅFISKLAG SA
NO0010797350
335
0.03 %
P
PEWI AS
NO0010797350
335
0.03 %
C
CASPER AS
NO0010797350
325
0.03 %
NO0010797350
314
0.03 %
NO0010797350
308
0.03 %
U
UNIQUM AS
NO0010797350
305
0.03 %
K
KVASSHØGDI AS
NO0010797350
305
0.03 %
NO0010797350
300
0.03 %
NO0010797350
300
0.03 %
N
NATHANIELSEN EIENDOM AS
NO0010797350
290
0.03 %
NO0010797350
290
0.03 %
NO0010797350
290
0.03 %
F
FAVN FORSIKRING
NO0010797350
284
0.03 %
H
HOKLAND HOLDING AS
NO0010797350
280
0.03 %
J
JAKOB HATTELAND HOLDING AS
NO0010797350
246
0.02 %
B
BRUNSBICA AS
NO0010797350
228
0.02 %
Z
ZERO INVEST AS
NO0010797350
228
0.02 %
C
CHILI HOLDING AS
NO0010797350
221
0.02 %
C
COUSI INVEST AS
NO0010797350
217
0.02 %
NO0010797350
217
0.02 %
S
SEAFOOD HOLDING AS
NO0010797350
210
0.02 %
T
T-M HOLDING AS
NO0010797350
204
0.02 %
I
IVAR JØRGENSEN INVEST AS
NO0010797350
203
0.02 %
NO0010797350
203
0.02 %
B
Bernhd. Brekke A/S
NO0010797350
203
0.02 %
NO0010797350
199
0.02 %
O
OLSEN HOLDING AS
NO0010797350
198
0.02 %
B
BEELINE AS
NO0010797350
194
0.02 %
N
NESARUS AS
NO0010797350
190
0.02 %
NO0010797350
189
0.02 %
NO0010797350
188
0.02 %
J
JÆGER INVEST AS
NO0010797350
183
0.02 %
T
TRIM INVEST AS
NO0010797350
183
0.02 %
A
AKKA INVEST AS
NO0010797350
178
0.02 %
J
JMO INVEST AS
NO0010797350
169
0.02 %
M
MARCO POLO AS
NO0010797350
169
0.02 %
I
INGUS AS
NO0010797350
169
0.02 %
P
POSSIDO AS
NO0010797350
168
0.02 %
C
CULEX AS
NO0010797350
167
0.02 %
J
JTT AS
NO0010797350
167
0.02 %
NO0010797350
166
0.02 %
W
WIST HOLDING AS
NO0010797350
163
0.02 %
K
KJH INVEST AS
NO0010797350
162
0.02 %
NO0010797350
161
0.02 %

Shares owned by the PHARMA HOLDINGS AS

NameShare classNumber of sharesShare
P
PEPTIDE PATENTS AS
Ordinary shares
5
50 %
P
PHARMASUM THERAPEUTICS AS
Ordinary shares
68,142
2.15 %
Last update: May 24, 2024

Financials

in NOK

Summary

Year202320222021
Total operating income
1,740,889
4,644,278
6,618,124
Annual Total Result
-15,173,542
-27,057,210
-13,746,133
Total assets
21,132,878
18,047,424
7,077,037
Total liabilities
4,779,598
2,620,602
896,773
Total equity
16,353,280
15,426,822
6,180,265

P&L

Year202320222021
Total operating income
1,740,889
4,644,278
6,618,124
Total operating costs
16,822,624
30,359,079
20,393,789
Operating result
-15,081,735
-25,714,801
-13,775,665
Financial income/costs
-91,808
-1,342,409
29,532
Profit before tax
-15,173,542
-27,057,210
-13,746,133
Total tax & extraordinary income/cost
0
0
0
Annual Total Result
-15,173,542
-27,057,210
-13,746,133

Balance overview

Year202320222021
Total fixed assets
6,491,302
1,258,519
1,258,519
Total current assets
14,641,576
16,788,905
5,818,518
Total assets
21,132,878
18,047,424
7,077,037
Short term debt
4,677,143
2,518,147
896,773
Long term debt
102,455
102,455
0
Total liabilities
4,779,598
2,620,602
896,773
Contributed capital
16,353,280
36,874,476
6,180,265
Retained earnings
0
-21,447,654
0
Total equity
16,353,280
15,426,822
6,180,265
Total equity and liabilities
21,132,878
18,047,424
7,077,037

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology